Gildan Board of Directors Resigns
23 mai 2024 17h55 HE
|
Gildan Activewear, Inc.
Vince Tyra has Stepped Down as President and CEOSale Process has Ceased MONTREAL, May 23, 2024 (GLOBE NEWSWIRE) -- Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or “the Company”) today...
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine receptor 8 (CCR8) Antibody, CHS-114, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
23 mai 2024 17h51 HE
|
Coherus BioSciences, Inc.
CHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective depletion of peripheral CCR8+ regulatory T...
Parks! America, Inc. Announces Glass Lewis Recommends Parks! America Shareholders Vote “FOR” Each of the Director Nominees Recommended by the Board
23 mai 2024 17h49 HE
|
Parks! America, Inc.
Glass Lewis Recommends Shareholders Vote on Parks! America’s WHITE Proxy Card Glass Lewis Recommends Voting “FOR” CEO Lisa Brady Parks! America Reminds Shareholders to Vote Today on the...
CORRECTION – The Herzfeld Caribbean Basin Fund, Inc. Announces Distribution in Stock and Cash
23 mai 2024 17h49 HE
|
Herzfeld Caribbean Basin Fund
MIAMI BEACH, Fla., May 23, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by The Herzfeld Caribbean Basin Fund, Inc. (NASDAQ: CUBA) (the “Fund”), please note that...
3Daughters to Participate in Women’s Health Panel During the 2024 BIO International Convention in San Diego, CA, June 3-6
23 mai 2024 17h33 HE
|
3Daughters
MANSFIELD, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, announced that Mary Beth Cicero, Co-Founder and CEO,...
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting
23 mai 2024 17h30 HE
|
Elicio Therapeutics, Inc.
ELI-002 7P administered as a monotherapy was well tolerated and able to generate a ~100x mKRAS-specific expanded T cell response relative to baseline levelsELI-002 7P generated an mKRAS-specific T...
Premier Health Reports 2024 Second Quarter Results
23 mai 2024 17h30 HE
|
Premier Health of America Inc.
MONTRÉAL, May 23, 2024 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation”), a leading Canadian Healthtech company, announces it has filed its Unaudited Quarterly...
Titanium Transportation Group Declares Quarterly Dividend
23 mai 2024 17h30 HE
|
Titanium Transportation Group Inc
BOLTON, Ontario, May 23, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Titanium Transportation Group Inc. (“Titanium” or the “Company”) (TSX:TTNM, OTCQX:TTNMF) has declared a quarterly dividend...
ALT Stockholders: Robbins LLP Reminds ALT Stockholders of Securities Fraud Class Action Against Altimmune, Inc.
23 mai 2024 17h29 HE
|
Robbins LLP
Robbins LLP is Investigating the Allegations that Altimmune, Inc. (ALT) Misled Investors Regarding the Viability and Efficacy of its Weight Loss Drug
MTTR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Matterport to CoStar Group
23 mai 2024 17h25 HE
|
Wohl & Fruchter LLP
We are investigating the fairness of the sale of Matterport to CoStar Group for $5.50 per share.